Advertisement

Pediatric Cardiology

, 27:636 | Cite as

No Evidence for Angiotensin Type 2 Receptor Gene Polymorphism in Intron 1 in Patients with Coarctation of the Aorta and Ullrich–Turner Syndrome

  • E. Struwe
  • K. Krammer
  • J. DötschEmail author
  • M. Metzler
  • H.G. Dörr
  • R. Cesnjevar
  • W. Rascher
  • A. Koch
Article

Abstract

In male patients with congenital anomalies of the kidney and urinary tract, an increased incidence of a polymorphism in the angiotensin type 2 receptor gene (AT2R) has been identified. The AT2R has been shown to be involved in apoptosis, particularly during embryogenesis. The aim of this study was to examine the A→1675G transition polymorphism in intron 1 of the AT2R gene that is located on the X chromosome in patients with coarctation of the aorta (CoA) with and without Ullrich–Turner syndrome (UTS). Screening of DNA samples was performed with restriction fragment length polymorphism analysis. Ninety-seven patients with CoA, 28 girls with UTS, 10 girls with UTS and CoA, and 96 control individuals were studied. There was no significant difference in the distribution of A and G-genotypes in any of the patient groups compared to controls. An A→1675G transition in the AT2R gene seems not to be involved in the pathogenesis of aortic coarctation.

Keywords

AT2R gene Polymorphism Aortic coarctation Ullrich–Turner syndrome 

Notes

Acknowledgments

We thank Ulla Jacobs and Ida Allabauer for excellent technical assistance.

References

  1. 1.
    Baudin B (2002) Angiotensin II receptor polymorphisms in hypertension. Pharmacogenetic considerations. Pharmacogenomics 3:65–73PubMedCrossRefGoogle Scholar
  2. 2.
    Blackford LM (1928) Coarctation of the aorta. Arch Intern Med 41:702–735Google Scholar
  3. 3.
    Campbell M, Bayliss JH (1956) The course and prognosis of coarctation of the aorta. Br Heart J 18:495Google Scholar
  4. 4.
    Carluccio M, Soccio M, De Caterina R (2001) Aspects of gene polymorphisms in cardiovascular disease: the renin–angiotensin system. Eur J Clin Invest 31:476–488PubMedCrossRefGoogle Scholar
  5. 5.
    Hiraoka M, Taniguchi T, Nakai H, et al. (2001) No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int 59:1244–1249PubMedCrossRefGoogle Scholar
  6. 6.
    Horiuchi M, Aldshita M, Dzau VJ (1998) Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 24:307–314PubMedCrossRefGoogle Scholar
  7. 7.
    Junker R, Kotthoff S, Vielhaber H, et al. (2001) Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 51:251–254PubMedCrossRefGoogle Scholar
  8. 8.
    Kakuchi J, Ichiki T, Kiyama S, et al. (1995) Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47:140–147PubMedGoogle Scholar
  9. 9.
    Katsuya T, Horiuchi M, Minami S, et al. (1997) Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome. Mol Cell Endocrinol 127:221–228PubMedCrossRefGoogle Scholar
  10. 10.
    Lopez JJ, Lorell BH, Ingelfinger JR, et al. (1994) Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 267:H844–H852PubMedGoogle Scholar
  11. 11.
    Maitland-van der Zee AH, Klungel OH, Stricker BH, et al. (2002) Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors. Atherosclerosis 163:213–222PubMedCrossRefGoogle Scholar
  12. 12.
    Mazzanti L, Cacciari E (1998) Congenital heart disease in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 133:688–692PubMedGoogle Scholar
  13. 13.
    Nagashima H, Sakomura Y, Aoka Y, et al. (2001) Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan’s syndrome. Circulation 104:I282–I287PubMedGoogle Scholar
  14. 14.
    Nakajima M, Hutchinson HG, Fujinaga M, et al. (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the ATI receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663–10667PubMedCrossRefGoogle Scholar
  15. 15.
    Nishimura H, Yerkes E, Hohenfellner K, et al. (1999) Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3:1–10PubMedCrossRefGoogle Scholar
  16. 16.
    Niu T, Chen X, Xu X (2002) Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 62:977–993PubMedCrossRefGoogle Scholar
  17. 17.
    Oshima K, Miyazaki Y, Brock JW III, et al. (2001) Angiotensin type II receptor expression and ureteral budding. J Urol 166:1848–1852PubMedCrossRefGoogle Scholar
  18. 18.
    Otsuka S, Sugano M, Makino N, et al. (1998) Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32:467–472PubMedGoogle Scholar
  19. 19.
    Price RL, Carver W, Simpson DG, et al. (1997) The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns. Dev Biol 192:572–584PubMedCrossRefGoogle Scholar
  20. 20.
    Ranke MB, Saenger P (2001) Turner’s syndrome. Lancet 358:309–314PubMedCrossRefGoogle Scholar
  21. 21.
    Song K, Shiota N, Takai S, et al. (1998) Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys. Atherosclerosis 138:171–182PubMedCrossRefGoogle Scholar
  22. 22.
    Stoll M, Steckelings UM, Paul M, et al. (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651–657PubMedCrossRefGoogle Scholar
  23. 23.
    Towbin JA, Belmont J (2000) Molecular determinants of left and right outflow tract obstruction. Am J Med Genet 97:297–303PubMedCrossRefGoogle Scholar
  24. 24.
    Yamada T, Akishita M, Pollman MJ, et al. (1998) Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 63:L289–L295CrossRefGoogle Scholar
  25. 25.
    Yamada T, Horiuchi M, Dzau VJ (1996) Angiotensin II type 2 receptor mediates programmed cell death. Prog Natl Acad Sci USA 93:156–160CrossRefGoogle Scholar
  26. 26.
    Zemel S, Millan MA, Feuillan P, Aguilera G (1990) Characterization and distribution of angiotensin-II receptors in the primate fetus. J Clin Endocrinol Metab 71:1003–1007PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • E. Struwe
    • 1
  • K. Krammer
    • 1
  • J. Dötsch
    • 1
    Email author
  • M. Metzler
    • 1
  • H.G. Dörr
    • 1
  • R. Cesnjevar
    • 2
  • W. Rascher
    • 1
  • A. Koch
    • 1
  1. 1.Children’s Hospital, University of Erlangen-NürnbergErlangenGermany
  2. 2.Center of Cardiac Surgery, University of Erlangen-NürnbergErlangenGermany

Personalised recommendations